Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05824559 |
Title | ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | MEI Pharma, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Southern California | Los Angeles | California | 90033 | United States | Details | |
Mount Sinai Miami | Miami Beach | Florida | 33140 | United States | Details | |
Johns Hopkins | Baltimore | Maryland | 21218 | United States | Details | |
Rutgers University | New Brunswick | New Jersey | 08901 | United States | Details | |
Mt Sinai New York | New York | New York | 10029 | United States | Details | |
Vanderbilt -Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
University of Utah | Salt Lake City | Utah | 84108 | United States | Details |